Detalles de la búsqueda
1.
Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
Breast Cancer Res Treat
; 184(2): 543-558, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876910
2.
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
Breast Cancer Res Treat
; 176(2): 407-417, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31006821
3.
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 19(6): 799-811, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753703
4.
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Lancet Oncol
; 16(4): 447-56, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25800891
5.
A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer.
BMC Cancer
; 12: 423, 2012 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23006447
6.
Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
Exp Mol Pathol
; 93(1): 154-61, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22504106
7.
Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients.
J Egypt Natl Canc Inst
; 34(1): 31, 2022 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35871690
8.
Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus.
J Egypt Natl Canc Inst
; 34(1): 56, 2022 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36567400
9.
Patient-mediated factors predicting early- and late-stage presentation of breast cancer in Egypt.
Psychooncology
; 20(5): 532-7, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21456061
10.
Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer in the Middle East and North Africa.
JCO Glob Oncol
; 7: 1556-1563, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34788123
11.
Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy.
Clin Pharmacol Drug Dev
; 8(6): 837-843, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30570831
12.
Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study.
Lung Cancer Manag
; 8(3): LMT15, 2019 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807143
13.
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.
Lancet Respir Med
; 7(7): 569-580, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31103412
14.
Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: a Phase II trial.
Urol Oncol
; 26(2): 133-6, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18312930
15.
Contributing factors to the outcome of primary malignant chest wall tumors.
J Thorac Dis
; 9(12): 5184-5193, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29312725
16.
Efficacy and Toxicity of Metronomic Chemotherapy in Metastatic Breast Cancer: Egyptian Experience.
Clin Breast Cancer
; 17(8): 618-628, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28625341
17.
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma.
Clin Lung Cancer
; 18(5): 589-593, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28690011
18.
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
J Clin Oncol
; 23(28): 6881-9, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16192580
19.
Teaching oncology to medical students is a must: the Egyptian NCI step on the road.
J Cancer Educ
; 26(3): 547-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21442386
20.
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.
J Clin Oncol
; 21(21): 3909-17, 2003 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14581415